Yemaachi Biotechnology
Expanding precision cancer solutions in Africa through genetic diversity.
Founded
2020Accelerator
Expanding precision cancer solutions in Africa through genetic diversity.
Founded with the mission to diversify and expand access to precision cancer diagnostics and therapeutics, Yemaachi Biotechnology focuses on leveraging the genetic diversity of African populations. By collecting and sequencing samples from across Africa, Yemaachi aims to optimize existing diagnostic tests and aid in the discovery of new ones. Their core services include advanced cancer diagnostics and research-driven solutions tailored to the unique genetic makeup of African populations, addressing a critical gap in global healthcare.
Notable figures affiliated with Yemaachi include experts in oncology and genomics, contributing to its robust research agenda. The company has garnered attention for its innovative approach and has been involved in significant initiatives such as the AfriCAN Webinar series. Yemaachi's key achievements include pioneering research that enhances the understanding of cancer in genetically diverse populations, thereby impacting global precision oncology. Their work is instrumental in developing more effective cancer treatments and diagnostics, particularly for underrepresented groups.
Companies similar to Yemaachi Biotechnology include Isabl, Epinoma, Serinus Biosciences and Clear Gene.
Yemaachi Biotechnology was founded in 2020.
Yemaachi Biotechnology's most recent funding round was for $125k (USD) in January 2021.
As of Jan 1, 2021, Yemaachi Biotechnology has disclosed funding of $125k (USD). Undisclosed round amounts are excluded.
Yemaachi Biotechnology has 16 employees as of Aug 23, 2023.
Clear Gene
cleargene.com
